Kazumasa Kotake

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 27

Top Topics

Systematic Review

Alcohol Use Disorder

Top Venues

Addiction (Abingdon, England)

British journal of clinical pharmacology

Basic & clinical pharmacology & toxicology

International journal of clinical pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Kazumasa Kotake, Tomonari Hosokawa, Masuo Tanaka, Ryuhei So, Masahiro Banno, Yuki Kataoka, Akihiro Shiroshita, Yasuhiko Hashimoto
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis. Addiction (Abingdon, England) 119 (5) (2024)
Kazumasa Kotake, Tomonari Hosokawa, Masuo Tanaka, Ryuhei So, Masahiro Banno, Yuki Kataoka, Akihiro Shiroshita, Yasuhiko Hashimoto
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis. Addiction (Abingdon, England) 119 (5) (2024)
Kazumasa Kotake
Comment on "The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis". International journal of clinical pharmacy 46 (4) (2024)
Satoru Mitsuboshi, Makoto Morizumi, Kazumasa Kotake, Ryohei Kaseda, Ichiei Narita
Individual dipeptidyl peptidase-4 inhibitors and acute kidney injury in patients with type 2 diabetes: A systematic review and network meta-analysis. Basic & clinical pharmacology & toxicology 135 (1) (2024)
Kazumasa Kotake
Comment on "The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis". International journal of clinical pharmacy (2024)
Akiko Yamada, Akira Watanabe, Atsushi Nara, Naozumi Ishimaru, Kosuke Maeda, Yusuke Ido, Kazumasa Kotake, Masatake Asano, Yasuo Shinohara, Takenori Yamamoto
Longitudinal Analysis of Mitochondrial Function in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis Mouse Model. International journal of molecular sciences 25 (11) (2024)
Kazumasa Kotake, Satoru Matsunuma, Naoya Kitamura, Yumi Noritake, Yasuhiro Kawakami
Preventive effects of first-generation antihistamine on emergence agitation or delirium: a systematic review. European journal of clinical pharmacology (2024)
Kazumasa Kotake, Tomonari Hosokawa, Masuo Tanaka, Ryuhei So, Masahiro Banno, Yuki Kataoka, Akihiro Shiroshita, Yasuhiko Hashimoto
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis. Addiction (Abingdon, England) 119 (5) (2024)
Satoru Mitsuboshi, Makoto Morizumi, Kazumasa Kotake, Ryohei Kaseda, Ichiei Narita
Individual dipeptidyl peptidase-4 inhibitors and acute kidney injury in patients with type 2 diabetes: A systematic review and network meta-analysis. Basic & clinical pharmacology & toxicology (2024)
Satoru Mitsuboshi, Makoto Morizumi, Kazumasa Kotake, Ryohei Kaseda, Ichiei Narita
Individual dipeptidyl peptidase-4 inhibitors and acute kidney injury in patients with type 2 diabetes: A systematic review and network meta-analysis. Basic & clinical pharmacology & toxicology 135 (1) (2024)
Akiko Yamada, Akira Watanabe, Atsushi Nara, Naozumi Ishimaru, Kosuke Maeda, Yusuke Ido, Kazumasa Kotake, Masatake Asano, Yasuo Shinohara, Takenori Yamamoto
Longitudinal Analysis of Mitochondrial Function in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis Mouse Model. International journal of molecular sciences 25 (11) (2024)
Kazumasa Kotake, Tomonari Hosokawa, Masuo Tanaka, Ryuhei So, Masahiro Banno, Yuki Kataoka, Akihiro Shiroshita, Yasuhiko Hashimoto
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis. Addiction (Abingdon, England) 119 (5) (2024)
Kazumasa Kotake, Tomonari Hosokawa, Masuo Tanaka, Ryuhei So, Masahiro Banno, Yuki Kataoka, Akihiro Shiroshita, Yasuhiko Hashimoto
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis. Addiction (Abingdon, England) (2024)
Kazumasa Kotake, Tomonari Hosokawa, Masuo Tanaka, Ryuhei So, Masahiro Banno, Yuki Kataoka, Akihiro Shiroshita, Yasuhiko Hashimoto
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis. Addiction (Abingdon, England) 119 (5) (2024)
Kazumasa Kotake, Tomonari Hosokawa, Masuo Tanaka, Ryuhei So, Masahiro Banno, Yuki Kataoka, Akihiro Shiroshita, Yasuhiko Hashimoto
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis. Addiction (Abingdon, England) 119 (5) (2024)
Kazumasa Kotake, Tomonari Hosokawa, Masuo Tanaka, Ryuhei So, Masahiro Banno, Yuki Kataoka, Akihiro Shiroshita, Yasuhiko Hashimoto
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis. Addiction (Abingdon, England) 119 (5) (2024)
Kazumasa Kotake, Yumi Noritake, Yasuhiro Kawakami
Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan. International journal of clinical pharmacy (2023)
Satoru Mitsuboshi, Kazumasa Kotake
Association between use of febuxostat and muscle injury: A disproportionality analysis and meta-analysis of randomized controlled trials. British journal of clinical pharmacology 89 (3) (2023)
Satoru Mitsuboshi, Kazumasa Kotake
Association between use of febuxostat and muscle injury: A disproportionality analysis and meta-analysis of randomized controlled trials. British journal of clinical pharmacology 89 (3) (2023)
Satoru Mitsuboshi, Kazumasa Kotake
Association between use of febuxostat and muscle injury: A disproportionality analysis and meta-analysis of randomized controlled trials. British journal of clinical pharmacology 89 (3) (2023)
Satoru Mitsuboshi, Kazumasa Kotake, Takeru Takahashi, Koji Sato, Toshiyuki Sakamaki
Association between misoprostol and non-steroidal anti-inflammatory drug-induced kidney injury: a systematic review and meta-analysis. British journal of clinical pharmacology (2023)
Satoru Mitsuboshi, Makoto Morizumi, Kazumasa Kotake, Ryohei Kaseda, Ichiei Narita
Urate-Lowering Drugs And Muscle Injury: A Systematic Review and Network Meta-Analysis. Journal of clinical pharmacology (2023)
Satoru Mitsuboshi, Kazumasa Kotake
Association between use of febuxostat and muscle injury: A disproportionality analysis and meta-analysis of randomized controlled trials. British journal of clinical pharmacology (2022)
Kazumasa Kotake, Satoru Mitsuboshi, Yasuhiro Kawakami
Evaluation of Preoperative Risk Factors for Sugammadex-Induced Anaphylaxis: Analysis of the Japanese Adverse Drug Event Report Database. Journal of clinical pharmacology 62 (12) (2022)
Satoru Mitsuboshi, Kazumasa Kotake
Association between use of febuxostat and muscle injury: a disproportionality analysis and meta-analysis of randomized controlled trials. British journal of clinical pharmacology (2022)
Kazumasa Kotake, Satoru Mitsuboshi, Yuki Omori, Yukio Kawakami, Yasuhiro Kawakami
Evaluation of Risk of Cardiac or Cerebrovascular Events in Romosozumab Users Focusing on Comorbidities: Analysis of the Japanese Adverse Drug Event Report Database. The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians 39 (1) (2022)
Kazumasa Kotake, Satoru Mitsuboshi, Yuki Omori, Yukio Kawakami, Yasuhiro Kawakami
Evaluation of Risk of Cardiac or Cerebrovascular Events in Romosozumab Users Focusing on Comorbidities: Analysis of the Japanese Adverse Drug Event Report Database. The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians 39 (1) (2022)